Oncology Institute, Inc. - *W EXP 99/99/999 (TOIIW)

CUSIP: 68236X118

Q2 2024 13F Holders as of 30 Jun 2024

Type / Class
Equity / *W EXP 99/99/999
Total 13F shares
4,210,487
Share change
+107,789
Total reported value
$107,613
Price per share
$0.03
Number of holders
15
Value change
+$2,833
Number of buys
6

Quarterly Holders Quick Answers

What is CUSIP 68236X118?
CUSIP 68236X118 identifies TOIIW - Oncology Institute, Inc. - *W EXP 99/99/999 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Oncology Institute, Inc. - *W EXP 99/99/999 (TOIIW) as of Q2 2024

As of 30 Jun 2024, Oncology Institute, Inc. - *W EXP 99/99/999 (TOIIW) was held by 15 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 4,210,487 shares. The largest 10 holders included LMR Partners LLP, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), Walleye Capital LLC, Davidson Kempner Capital Management LP, FreeGulliver LLC, Man Group plc, HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND, COWEN AND COMPANY, LLC, WOLVERINE ASSET MANAGEMENT LLC, and TWO SIGMA INVESTMENTS, LP. This page lists 15 institutional shareholders reporting positions in this security for the Q2 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.